INS and type 2 diabetes mellitus: In a Swedish population study using GADA 250 IU/mL as a cutoff and dividing the patients into high or low, the percentage of patients requiring insulin therapy at 6 months was 42.2% for the high-titer group compared with 3.7% for phenotypic type 2 diabetes [19].